SG Americas Securities’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-213,490
Closed -$45.4M 3505
2014
Q4
$45.4M Buy
213,490
+140,675
+193% +$28M 0.22% 87
2014
Q3
$13M Sell
72,815
-176,087
-71% -$29.2M 0.08% 261
2014
Q2
$42.1M Buy
248,902
+44,320
+22% +$6.9M 0.24% 82
2014
Q1
$25.4M Buy
204,582
+90,401
+79% +$11M 0.11% 212
2013
Q4
$12.7M Sell
114,181
-62,259
-35% -$5.95M 0.05% 357
2013
Q3
$16M Sell
176,440
-29,926
-15% -$2.69M 0.07% 275
2013
Q2
$17.4M Buy
+206,366
New +$21.4M 0.09% 243

Other funds holding AGN

SG Americas Securities's AGN Position: Q1 2015 in Review

SG Americas Securities sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 213,490 shares — an estimated $45.4M sold.

SG Americas Securities first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $45.4M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • SG Americas Securities reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • SG Americas Securities sold 213,490 Allergan Inc shares in Q1 2015, an estimated $45.4M.
  • SG Americas Securities first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • SG Americas Securities's Allergan Inc position peaked at $45.4M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on SG Americas Securities's 13F filing for Q1 2015, filed 13 May 2015.